BMS, Novartis Sue Teva Over HIV Drug Reyataz

Law360, New York (March 12, 2010, 12:36 PM EST) -- Bristol Myers-Squibb Co. and Novartis Corp. have sued generic-drug maker Teva Pharmaceuticals USA Inc. over its attempt to introduce its own version of HIV treatment Reyataz before the drug's patents expire.

The pharmaceuticals giants filed suit Thursday in the U.S. District Court for the District of Delaware, asserting two patents for the drug, one of which belongs to BMS and another that BMS licenses from Novartis.

The complaint comes in response to a letter the plaintiffs received from Teva on Feb. 17 indicating the generics maker...
To view the full article, register now.